Home > Drug Search >
  • company_query: Active Biotech
  •   > 
Drug Filter
Category:
chemistry (49) biology (13)
Status:
Approved (7) NDA Filing (1) BLA Filing (2) Phase Ⅲ (8) Phase Ⅱ (27) Phase Ⅰ (16) IND Filing (1)
Clinical Stage:
Pending (3) Active (38) Discontinued (13)
Bio-Type:
Vaccine (1) Blood extraction (1) Recombinant enzyme (1) Recombinant polypeptide (1) Recombinant cytokines (1) Recombinant hormone (1) Whole antibody (5) ADC (1) Fusion protein (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Advanced renal cell carcinoma (RCC) (1) Alzheimer's disease (AD) (2) Asthma (5) Bladder cancer (2) Breast cancer (1) Candidiasis (1) Agammaglobulinaemia (1) Chronic obstructive pulmonary disease (COPD) (7) Cutaneous fungal infections (1) Duodenal ulcer (1) Fibromyalgia (FM) (1) Growth hormone deficit (1) HBV infection (1) HCV infection (1) Heart failure (2) HIV infection (2) Hypercholesterolemia (1) Hypertension (1) Influenza virus infection (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Stevens-Johnson syndrome (1) Toxic epidermal necrolysis (1) Leukemia (1) Metastatic breast cancer (1) Metastatic castration-resistant prostate cancer (mCRPC) (1) Migraine (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (2) Opioid induced constipation (OIC) (1) Osteoporosis (1) Pancreatic cancer (2) Peptic ulcer (1) Kidney disorders (1) Prostate cancer (2) Psoriasis (1) Rheumatoid arthritis (RA) (7) Solid tumours (4) Systemic lupus erythematosus (1) Type 2 diabetes (1) Ulcerative colitis (2) Ventilator-associated pneumonia (1) Colorectal cancer (1) Nosocomial Pneumonia (NP) (1) Chronic kidney disease (1) Colon cancer (1) Complicated skin and skin structure infections (cSSSI) (1) Neuroblastoma (1) Staphylococcus aureus bloodstream infections (1) Age-related macular degeneration (AMD) (1) Trichophyton rubrum infection (1) Epidermophyton floccosum infection (1) Ringworm (1) Tinea versicolor (1) HER2-positive metastatic breast cancer (1) Autoimmune diseases (1) Growth failure (1) Esophageal adenocarcinoma (1) Gastroparesis diabeticorum (1) Gram-positive bacterial infection (3) Gastrointestinal motility disorders (2) Squamous cell carcinoma of head and neck cancer (SCCHN) (1) Systemic sclerosis (1) Port wine stain (1) Gastrointestinal disorders (1) Stem cell mobilization (1) Bacterial infection (1) hematological malignancies (1) Cardiovascular disorders (1) Sciatica (1) Inflammation (1) Pemphigus vulgaris (1) Nontuberculous Mycobacteria (1)
Country:
Aprv. Year:
1996 (1) 2009 (1) 2012 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top